On this site you will find clinical studies with cannabis or single
cannabinoids in different diseases and case reports on the use of cannabis by
You may search for diseases (indications), authors, medication, study design (controlled study, open trial, case report etc.) and other criteria.
|Title||Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of DEMENTIA: An-Open Label, Add-On, Pilot Study.|
|Author(s)||Shelef A, Barak Y, Berger U, Paleacu D, Tadger S, Plopsky I, Baruch Y.|
|Journal, Volume, Issue||J Alzheimers Dis. 2016;51(1):15-9. doi: 10.3233/JAD-150915.|
|Major outcome(s)||Following aspects significantly decreased: Delusions, agitation/aggression, irritability, apathy, and sleep and caregiver distress|
BACKGROUND: Tetrahydrocannabinol (THC) is a potential treatment for Alzheimer's disease (AD). OBJECTIVE: To measure efficacy and safety of medical cannabis oil (MCO) containing THC as an add-on to pharmacotherapy, in relieving behavioral and psychological symptoms of DEMENTIA (BPSD). METHODS: Eleven AD patients were recruited to an open label, 4 weeks, prospective trial. RESULTS: Ten patients completed the trial. Significant reduction in CGI severity score (6.5 to 5.7; p <  0.01) and NPI score were recorded (44.4 to 12.8; p <  0.01). NPI domains of significant decrease were: Delusions, agitation/aggression, irritability, apathy, sleep and caregiver distress. CONCLUSION: Adding MCO to AD patients' pharmacotherapy is safe and a promising treatment option.
|Participants||Ten patients with Alzheimer’s disease|
|Type of publication||Medical journal|
|Address of author(s)||Abarbanel Mental Health Center, Bat-Yam, Israel and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.|